BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Diagnosis
10 results:

  • 1. Evaluations of the combined use of blood- and tissue-based protein biomarkers for pancreatic cancer.
    Wiewiora M; Jopek J; Świętochowska E; Grynkiewicz M; Piecuch J
    Clin Hemorheol Microcirc; 2024; 86(3):383-393. PubMed ID: 37955083
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Blood-based protein biomarkers and red blood cell aggregation in pancreatic cancer.
    Wiewiora M; Jopek J; Świętochowska E; Sławomir G; Piecuch J; Gąska M; Piecuch J
    Clin Hemorheol Microcirc; 2023; 85(4):371-383. PubMed ID: 37718785
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p/BPTF axis and degrading BIN1.
    Lin J; Wang X; Zhai S; Shi M; Peng C; Deng X; Fu D; Wang J; Shen B
    J Hematol Oncol; 2022 Sep; 15(1):128. PubMed ID: 36068586
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Studying the Anti-Tumor Effects of siRNA Gene Silencing of Some Metabolic Genes in pancreatic Ductal Adenocarcinoma.
    Al Hanjori AS; Alshaer W; Al-Anati B; Wehaibi S; Zihlif M
    Curr Mol Pharmacol; 2021 Oct; 14(4):604-619. PubMed ID: 33045974
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hypoxia-Induced TGFBI as a Serum Biomarker for Laboratory diagnosis and Prognosis in Patients with pancreatic Ductal Adenocarcinoma.
    Yang L; Cui R; Li Y; Liang K; Ni M; Gu Y
    Lab Med; 2020 Jul; 51(4):352-361. PubMed ID: 31626700
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote pancreatic cancer Metastasis.
    Wang X; Luo G; Zhang K; Cao J; Huang C; Jiang T; Liu B; Su L; Qiu Z
    Cancer Res; 2018 Aug; 78(16):4586-4598. PubMed ID: 29880482
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. High expression of hif1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF.
    Hoffmann AC; Mori R; Vallbohmer D; Brabender J; Klein E; Drebber U; Baldus SE; Cooc J; Azuma M; Metzger R; Hoelscher AH; Danenberg KD; Prenzel KL; Danenberg PV
    Neoplasia; 2008 Jul; 10(7):674-9. PubMed ID: 18592007
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Acute pancreatitis presenting as sudden, unexpected death: an autopsy-based study of 27 cases.
    Tsokos M; Braun C
    Am J Forensic Med Pathol; 2007 Sep; 28(3):267-70. PubMed ID: 17721182
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Lipid-rich variant of pancreatic endocrine neoplasms.
    Singh R; Basturk O; Klimstra DS; Zamboni G; Chetty R; Hussain S; La Rosa S; Yilmaz A; Capelli P; Capella C; Cheng JD; Adsay NV
    Am J Surg Pathol; 2006 Feb; 30(2):194-200. PubMed ID: 16434893
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation.
    Akakura N; Kobayashi M; Horiuchi I; Suzuki A; Wang J; Chen J; Niizeki H; Kawamura Ki ; Hosokawa M; Asaka M
    Cancer Res; 2001 Sep; 61(17):6548-54. PubMed ID: 11522653
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.